Terry Gould is a Senior Partner in Growth Equity at Adams Street Partners. See sector focus and contact routes.
Terry Gould is a Senior Partner in Growth Equity at Adams Street Partners, where he invests in venture and growth-oriented companies with a primary focus on healthcare, including medical devices and biopharma[1][2]. Before joining Adams Street, he worked at Trinity Ventures, Ltd., spent five years as a management consultant at Boston Consulting Group, and served as a founder and executive in two entrepreneurial companies[1]. His investment thesis targets healthcare sectors across venture and growth stages, with no explicit geographic restrictions beyond the firm’s Chicago base[1][2]. While specific check sizes and lead/follow behavior are not publicly detailed, his portfolio includes both current investments like Corvus Pharmaceuticals, Epirium Bio, Mineralys Therapeutics, and Palvella Therapeutics, and past investments such as Jazz Pharmaceuticals and Pharmacyclics[1]. Gould has held director roles at multiple portfolio companies including Orbus Therapeutics, Outpost Medicine, Partner Therapeutics, and Qpex Biopharma, indicating active involvement beyond capital provision[4]. No distinctive public writing or unique point of view is documented in available sources, though his caree
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Chicago.
Investors like Terry Gould · Full investor directory · Investor access · Company funding database